Medpace Holdings (MEX:MEDP) Forward PE Ratio : 28.26 (As of Dec. 12, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Medpace Holdings Forward PE Ratio?

Medpace Holdings's Forward PE Ratio for today is 28.26.

Medpace Holdings's PE Ratio without NRI for today is 29.90.

Medpace Holdings's PE Ratio (TTM) for today is 29.90.

Medpace Holdings Forward PE Ratio Historical Data

The historical data trend for Medpace Holdings's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medpace Holdings Forward PE Ratio Chart

Medpace Holdings Annual Data

Trend

2019-11

2020-12

2021-12

2022-12

2023-12

2024-12

Forward PE Ratio

22.73

34.48

44.25

27.40

28.90

28.25

Medpace Holdings Quarterly Data
	2019-03	2019-06	2019-09	2020-03	2020-06	2020-09	2020-12	2021-03	2021-06	2021-09	2021-12	2022-09	2022-12	2023-03	2023-06	2023-09	2023-12	2024-03	2024-06	2024-09	2024-12
Forward PE Ratio	19.65	20.83	24.27	20.96	39.06	23.09	34.48	37.59	41.49	36.50	44.25	24.39	27.40	30.03	26.46	25.00	28.90	26.53	33.11	26.67	28.25

Competitive Comparison of Medpace Holdings's Forward PE Ratio

For the Diagnostics & Research subindustry, Medpace Holdings's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medpace Holdings's Forward PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Forward PE Ratio falls into.

Medpace Holdings Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.

Medpace Holdings (MEX:MEDP) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .

Medpace Holdings Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (MEX:MEDP) » Definitions » Forward PE Ratio

Comparable Companies

Traded in Other Exchanges

MEDP:USA 01P:Germany

Address

5375 Medpace Way, Cincinnati, OH, USA, 45227

Website

https://www.medpace.com

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.